Teleflex Incorporated (TFX)

Market Cap	5.43B
Revenue (ttm)	3.01B
Net Income (ttm)	149.39M
Shares Out	44.19M
EPS (ttm)	3.20
PE Ratio	38.41
Forward PE	9.14
Dividend	$1.36 (1.11%)
Ex-Dividend Date	Mar 7, 2025

Volume	711,045
Open	125.28
Previous Close	126.41
Day's Range	122.74 - 125.74
52-Week Range	124.66 - 249.91
Beta	1.17
Analysts	Hold
Price Target	176.50 (+43.66%)
Earnings Date	May 1, 2025

About TFX

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, the measurement of blood pressure, and the collection of blood samples. The company also offers interventional products, including various co...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1943
• Employees: 14,100
• Stock Exchange: NYSE
• Ticker Symbol: TFX
• Website: https://www.teleflex.com

Financial Performance

In 2024, Teleflex's revenue was $3.05 billion, an increase of 2.45% compared to the previous year's $2.97 billion. Earnings were $69.68 million, a decrease of -80.45%.

Analyst Forecast

According to 10 analysts, the average rating for TFX stock is "Hold." The 12-month stock price forecast is $176.5, which is an increase of 43.66% from the latest price.

Price Target

$176.5

(43.66% upside)

Analyst Consensus: Hold